G. Gandaglia

Epidemiology, Risk Factors, and Prevention of Prostate Cancer.

PSMA PET/CT Kinetics During Systemic Therapy and Radiotherapy in Hormone-sensitive Prostate Cancer: A Systematic Review

Take Home Message PSMA PET-derived volumetric data hold the potential to personalize treatment strategies depending on treatment response. Comprehensive data on PSMA expression dynamics, however, are still needed before this approach can be implemented in routine clinical practice.

Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with cryotherapy vs. external beam radiation therapy

Focal Therapy for Prostate Cancer.

This retrospective study uses data from the National Cancer Database to examine patterns and temporal trends in use of focal therapy for prostate cancer in US cancer centers; characterize inappropriate use in low-, high-, or very–high-risk disease; and describe intermediate-risk use.

Stage migration in prostate cancer: the role of PSMA-PET in identifying oligometastatic disease.

Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with focal therapy vs. radical prostatectomy.

INTRODUCTION Focal therapy (FT) in high-risk or very high-risk prostate cancer (CaP) is not guideline-recommended. However, it may be occasionally used, but its effect on cancer-specific mortality (CSM) relative to standard treatment options such as radical prostatectomy (RP) is unknown and was addressed in the present...